Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zelpultide alfa by Airway Therapeutics for Bronchopulmonary Dysplasia: Likelihood of Approval
Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Bronchopulmonary Dysplasia. According to GlobalData,...
Zelpultide alfa by Airway Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According...
Zelpultide alfa by Airway Therapeutics for Bronchopulmonary Dysplasia: Likelihood of Approval
Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Bronchopulmonary Dysplasia. According to GlobalData,...